Patent details
EP3164155 Title: TREPROSTINIL FORMULATIONS
Basic Information
- Publication number:
- EP3164155
- PCT Application Number:
- US2015035595
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP157314634
- PCT Publication Number:
- WO2015192030
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREPROSTINIL FORMULATIONS
- French Title of Invention:
- FORMULATIONS DE TRÉPROSTINIL
- German Title of Invention:
- TREPROSTINILFORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 12/06/2015
- Grant date:
- 09/02/2022
- EP Publication Date:
- 10/05/2017
- PCT Publication Date:
- 17/12/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/02/2022
- EP B1 Publication Date:
- 09/02/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/06/2022
- Expiration date:
- 12/06/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/02/2022
- Name:
- United Therapeutics Corporation
- Address:
- 1040 Spring Street, Silver Spring, MD 20910, United States (US)
Inventor
1
- Name:
- PHARES, Ken
- Address:
- United States (US)
2
- Name:
- CHANG, Courtney
- Address:
- United States (US)
Priority
- Priority Number:
- 201462011689 P
- Priority Date:
- 13/06/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 47/32; A61K 9/14; A61K 31/557; A61K 9/10; A61P 9/12;
Publication
European Patent Bulletin
- Issue number:
- 202206
- Publication date:
- 09/02/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|